Characterization of erythropoietin recep
โ
Jee-Yeong Jeong; Laurie Feldman; Peter Solar; Jolanta Szenajch; Arthur J. Sytkow
๐
Article
๐
2007
๐
John Wiley and Sons
๐
French
โ 501 KB
## Abstract The identification of erythropoietin receptors (EpoR) on cancer cells has caused concern, since it implies the possibility that treatment of cancer patients with erythropoietin (Epo) and related agents with demonstrable antiapoptotic activity could enhance cancer growth and progression.